Cargando…
Oxidized low‐density lipoproteins as a novel risk factor and therapeutic target for ACM
Arrhythmogenic cardiomyopathy (ACM) is an inherited heart disease involving arrhythmia in young adults accompanied by structural changes at later stages. In this issue of EMBO Molecular Medicine, Sommariva et al (2021) identified a positive correlation between circulating levels of oxidized low‐dens...
Autores principales: | Tsui, Hoyee, Han, Su Ji, van Rooij, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422066/ https://www.ncbi.nlm.nih.gov/pubmed/34411432 http://dx.doi.org/10.15252/emmm.202114789 |
Ejemplares similares
-
Lipoprotein(a): the underutilized risk factor for cardiovascular disease
por: Khan, TZ, et al.
Publicado: (2019) -
The mitochondrial ATP synthase as an ATP consumer—a surprising therapeutic target
por: Valdebenito, Gabriel E, et al.
Publicado: (2023) -
High-density lipoproteins delivering interleukin-15
por: Ochoa, Maria C., et al.
Publicado: (2013) -
Shiga toxin (Stx) type 2‐induced increase in O‐linked N‐acetyl glucosamine protein modification: a new therapeutic target?
por: Bova, Rebecca A, et al.
Publicado: (2021) -
Splicing therapeutics for Alzheimer's disease
por: Wasser, Catherine R, et al.
Publicado: (2016)